These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11216765)

  • 1. Induction of MAGE-3 expression in lung and esophageal cancer cells.
    Weiser TS; Ohnmacht GA; Guo ZS; Fischette MR; Chen GA; Hong JA; Nguyen DM; Schrump DS
    Ann Thorac Surg; 2001 Jan; 71(1):295-301; discussion 301-2. PubMed ID: 11216765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1.
    Weiser TS; Guo ZS; Ohnmacht GA; Parkhurst ML; Tong-On P; Marincola FM; Fischette MR; Yu X; Chen GA; Hong JA; Stewart JH; Nguyen DM; Rosenberg SA; Schrump DS
    J Immunother; 2001; 24(2):151-61. PubMed ID: 11265773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura.
    Schrump DS; Fischette MR; Nguyen DM; Zhao M; Li X; Kunst TF; Hancox A; Hong JA; Chen GA; Pishchik V; Figg WD; Murgo AJ; Steinberg SM
    Clin Cancer Res; 2006 Oct; 12(19):5777-85. PubMed ID: 17020984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential 5-Aza 2'-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells.
    Steiner FA; Hong JA; Fischette MR; Beer DG; Guo ZS; Chen GA; Weiser TS; Kassis ES; Nguyen DM; Lee S; Trepel JB; Schrump DS
    Oncogene; 2005 Mar; 24(14):2386-97. PubMed ID: 15735751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
    Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
    Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of 5-aza-2'-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells.
    Gagnon J; Shaker S; Primeau M; Hurtubise A; Momparler RL
    Anticancer Drugs; 2003 Mar; 14(3):193-202. PubMed ID: 12634613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
    Weber J; Salgaller M; Samid D; Johnson B; Herlyn M; Lassam N; Treisman J; Rosenberg SA
    Cancer Res; 1994 Apr; 54(7):1766-71. PubMed ID: 7511051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells.
    Shaker S; Bernstein M; Momparler LF; Momparler RL
    Leuk Res; 2003 May; 27(5):437-44. PubMed ID: 12620295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism.
    Hou SY; Sang MX; Geng CZ; Liu WH; Lü WH; Xu YY; Shan BE
    Arch Med Res; 2014 Jan; 45(1):44-51. PubMed ID: 24316396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative expression and immunogenicity of MAGE-3 and -6 in upper aerodigestive tract cancer.
    Filho PA; López-Albaitero A; Xi L; Gooding W; Godfrey T; Ferris RL
    Int J Cancer; 2009 Oct; 125(8):1912-20. PubMed ID: 19610063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of 5-aza-2'-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer.
    Gunda V; Cogdill AP; Bernasconi MJ; Wargo JA; Parangi S
    Surgery; 2013 Dec; 154(6):1456-62; discussion 1462. PubMed ID: 24238058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of MAGE genes in lymphoid cells by the demethylating agent 5-aza-2'-deoxycytidine.
    Shichijo S; Yamada A; Sagawa K; Iwamoto O; Sakata M; Nagai K; Itoh K
    Jpn J Cancer Res; 1996 Jul; 87(7):751-6. PubMed ID: 8698626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules.
    Adair SJ; Hogan KT
    Cancer Immunol Immunother; 2009 Apr; 58(4):589-601. PubMed ID: 18791715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
    Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
    Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants.
    Lin J; Lin L; Thomas DG; Greenson JK; Giordano TJ; Robinson GS; Barve RA; Weishaar FA; Taylor JM; Orringer MB; Beer DG
    Clin Cancer Res; 2004 Sep; 10(17):5708-16. PubMed ID: 15355897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of XAGE-1b, a short major transcript of cancer/testis-associated gene XAGE-1, induced in melanoma metastasis.
    Zendman AJ; van Kraats AA; den Hollander AI; Weidle UH; Ruiter DJ; van Muijen GN
    Int J Cancer; 2002 Jan; 97(2):195-204. PubMed ID: 11774264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma.
    Li B; Zhu X; Sun L; Yuan L; Zhang J; Li H; Ye Z
    Oncotarget; 2014 Nov; 5(21):10791-802. PubMed ID: 25301731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
    Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
    De Smet C; De Backer O; Faraoni I; Lurquin C; Brasseur F; Boon T
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7149-53. PubMed ID: 8692960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts.
    Srivastava P; Paluch BE; Matsuzaki J; James SR; Collamat-Lai G; Taverna P; Karpf AR; Griffiths EA
    Epigenetics; 2015; 10(3):237-46. PubMed ID: 25793777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.